Authors: Tam, RC Ramasamy, K Bard, J Pai, B Lim, C Averett, DR

Citation: Rc. Tam et al., The ribavirin analog ICN 17261 demonstrates reduced toxicity and antiviraleffects with retention of both immunomodulatory activity and reduction of hepatitis-induced serum alanine aminotransferase levels, ANTIM AG CH, 44(5), 2000, pp. 1276-1283

Authors: Ramasamy, KS Tam, TC Bard, J Averett, DR

Citation: Ks. Ramasamy et al., Monocyclic L-nucleosides with type 1 cytokine-inducing activity, J MED CHEM, 43(5), 2000, pp. 1019-1028

Authors: Zhang, WJ Ramasamy, KS Averett, DR

Citation: Wj. Zhang et al., Improved synthesis of 2-deoxy-L-ribose, NUCLEOS NUC, 18(11-12), 1999, pp. 2357-2365

Authors: Tam, RC Pai, B Bard, J Lim, C Averett, DR Phan, UT Milovanovic, T

Citation: Rc. Tam et al., Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile, J HEPATOL, 30(3), 1999, pp. 376-382

Authors: Jordan, I Briese, T Averett, DR Lipkin, WI

Citation: I. Jordan et al., Inhibition of Borna disease virus replication by ribavirin, J VIROLOGY, 73(9), 1999, pp. 7903-7906